Robert M. Tanguay – författare
Visar alla böcker från författaren Robert M. Tanguay. Handla med fri frakt och snabb leverans.
4 produkter
4 produkter
Del 51 - Annals of the New York Academy of Sciences
Aging, Cancer and Age-related Disease
Common Mechanisms?, Volume 1197
Häftad, Engelska, 2010
1 122 kr
Tillfälligt slut
This volume recognizes the rapidly expanding research linking aging, age-related diseases, and the delicate balance between neurodegeneration and cancer. Wide perspectives on aging are covered, ranging from metabolic and cellular interventions in aging, oxidative stress resistance, protein folding and quality control, as well as the troublesome relationship between prevention of chaperonopathies and the risk for cancer. Key Features: Explores current research linking aging, age-related diseases, neurodegeneration, and cancer. Includes papers presented at 13th Congress of the Association of Biomedical GerontologyPart of the Annals of the New York Academy of Sciences seriesThis book is ideal for Graduate students and researchers in the fields of biomedical gerontology, cell and molecular biology, neuroscience, and oncology.NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
2 207 kr
Skickas inom 10-15 vardagar
Based upon a workshop entitled “The Small HSP World” held in Québec 2-5 October 2014. Twenty-five scientists provided chapters for the book. The chapters are from the best scientists currently working in this field. These colleagues include Arrigo, Benesch, Benjamin, Buchner-Haslbeck-Weinkauf, Benndorf, Boelens, Carra, Chang, Currie, Ecroyd, Emanuelsson, Fu, Garrido, Golenhofen, Gusev, Hightower, Kampinga, Lavoie, MacRae, Quinlan, Tanguay, Vierling, Vigh, Weeks and Wu. Briefly, the book starts with the structure of small heat shock proteins, moving to their functions and finishing with their involvement in diseases. Although this is quite broad, the structural aspect will be the unifying theme of the book.
1 652 kr
Skickas inom 10-15 vardagar
Based upon a workshop entitled “The Small HSP World” held in Québec 2-5 October 2014. Twenty-five scientists provided chapters for the book. The chapters are from the best scientists currently working in this field. These colleagues include Arrigo, Benesch, Benjamin, Buchner-Haslbeck-Weinkauf, Benndorf, Boelens, Carra, Chang, Currie, Ecroyd, Emanuelsson, Fu, Garrido, Golenhofen, Gusev, Hightower, Kampinga, Lavoie, MacRae, Quinlan, Tanguay, Vierling, Vigh, Weeks and Wu. Briefly, the book starts with the structure of small heat shock proteins, moving to their functions and finishing with their involvement in diseases. Although this is quite broad, the structural aspect will be the unifying theme of the book.
Del 959 - Advances in Experimental Medicine and Biology
Hereditary Tyrosinemia
Pathogenesis, Screening and Management
Inbunden, Engelska, 2017
1 823 kr
Skickas inom 10-15 vardagar
Hereditary tyrosinemia type 1 (HT1), the most severe inborn error of the tyrosine degradation pathway, is due to a deficiency in fumarylacetoacetate hydrolase (FAH). The worldwide frequency of HT1 is one per 100,000 births, but some regions have a significantly higher incidence (1:1,800). The FAH defect results in the accumulation of toxic metabolites, mainly in the liver. If left untreated, HT1 is usually fatal before the age of two. HT1 patients develop several chronic complications including cirrhosis with a high risk of hepatocellular carcinoma (HCC) and neuropsychological impairment. Treatment comprises an inhibitor of the pathway, Nitisinone, a strict dietary treatment or liver transplantation. Early treatment is important to avoid HCC. The book includes the latest developments on the molecular basis of HT1, its pathology, screening and diagnosis and management of the disease written by leading scientists, geneticists, hepatologists and clinicians in the field.